CCL5 and neoplasm: Similarly, in mice inoculated with malignant melanoma, valsartan was found to reduce the production of the CC motif chemokine ligand CCL5 from fibroblasts, increase tumor-infiltrating T cells, and decrease regulatory T cells, which was accompanied by an increase in tumor antigen-specific T-cell responses [147].